Vanessa Williams Has Been Taking a GLP-1 for Weight Loss for 2 Years

Vanessa Williams is opening up about her health. The 62-year-old Ugly Betty actress and singer revealed she’s been taking a GLP-1 for weight loss for the past two years. Vanessa got candid in a new cover story, explaining that she began Mounjaro, a GLP-1 medication for people with Type 2 diabetes (which is also used […]

Novo CEO sees obesity pill opening doors to new markets

Novo Nordisk A/S’s obesity pill will allow it to tap into a massive population of patients that have not yet taken GLP-1s , the drugmaker’s chief executive said. The pill version of its blockbuster obesity shot Wegovy will expand the market for these drugs, CEO Mike Doustdar said at an Endpoints event in San Francisco […]

New Year, New Strategy: Navigating Weight Loss ETFs

With the start of 2026, the annual focus on weight loss resolutions presents a timely opportunity for financial advisors to discuss the investment potential of GLP-1 agonists with their clients. This class of drugs has fundamentally altered the healthcare sector’s growth projections. As the market matures, advisors are increasingly evaluating weight loss ETFs to capture […]